Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive ReviewTreatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
|
| 0 Comment
Continual lymphocytic leukemia (CLL) incidence will increase with age reaching 37.9/100,000 in sufferers over 85 years. Though there isn’t any standardized geriatric software particularly validated for CLL, an accurate framing